Clinical Trials Directory

Trials / Sponsors / Scios, Inc.

Scios, Inc.

Industry · 22 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
Heart Decompensation
Phase 32007-05-01
TerminatedNatrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
Congestive Heart Failure, Cardiac Transplantation, Renal Insufficiency
Phase 22006-09-01
CompletedSCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
Bone Marrow Diseases, Myelodysplastic Syndromes, Hematologic Diseases
Phase 22005-05-01
CompletedExtension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Mye
Multiple Myeloma
Phase 22004-11-01
CompletedSPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate
Arthritis, Rheumatoid
Phase 22004-07-01
CompletedRegistry for Acute Decompensated Heart Failure Patients Admitted to the ER
Heart Failure, Congestive, Heart Decompensation
2004-07-01
CompletedStudy of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
Multiple Myeloma
Phase 22004-06-01
CompletedA Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of
Heart Failure, Congestive
Phase 22004-04-01
CompletedClinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014
Coronary Artery Bypass Surgery, Coronary Heart Disease, Coronary Artery Bypass Grafting
Phase 22004-03-01
CompletedEvaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic
Congestive Heart Failure, Chronic Heart Failure
Phase 42003-03-01
CompletedLongitudinal Registry for Advanced Heart Failure Patients
Heart Failure, Congestive, Heart Decompensation
2002-10-01
CompletedFUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With
Heart Failure, Congestive
Phase 32001-12-01
CompletedRegistry for Acute Decompensated Heart Failure Patients
Heart Failure, Congestive, Heart Decompensation
2001-10-01
CompletedHeart Failure Registry
Heart Failure, Congestive
2001-09-01
CompletedA Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When N
Cardiomyopathies, Heart Failure, Congestive, Dyspnea, Paroxysma
Phase 32001-01-01
CompletedA Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo
Symptomatic Decompensated Congestive Heart Failure, Congestive Heart Failure in Acute Coronary Syndrome
Phase 31999-10-01
CompletedA Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failur
Heart Failure, Congestive
Phase 31998-08-01
CompletedA Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment
Heart Failure, Congestive, Heart Decompensation
Phase 31997-01-01
CompletedA Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Fai
Heart Failure, Congestive, Heart Decompensation
Phase 31996-10-01
CompletedA Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Dist
Rheumatoid Arthritis
Phase 1
CompletedSafety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
Rheumatoid Arthritis
Phase 2
WithdrawnAn Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing
Coronary Artery Bypass Surgery, Coronary Heart Disease, Coronary Artery Bypass Grafting
Phase 3